Citation: | Cao FengQin, . Observation on the effect of the plan of CA(E)P to treat non-small cell lung carcinoma[J]. Cancer Research on Prevention and Treatment, 1996, 23(1): 40-42. |
1. 孙燕.肺癌的化学治疗和综合治疗.肿瘤防治研究,1984, 11(2):108.
|
2. 孙燕.肺癌治疗方法选择.中华结核和呼吸系统疾病,1986, 9(3):179.
|
3. 廖美琳.肺癌扩大根治术指征限度.中华结核和呼吸系统疾病,1986. 9(3):179.
|
4. 廖美琳.肺癌治疗近况和发展.国外医学肿瘤分册,1993, 20(4):217.
|
5. A. X TpaxMeHfiep Jak uikolo lup uemoga leleHUl uockba uyganelbcmfo (uegHUHaI), 1987,240.
|
6. 林道平.肺癌防治研究之进展·癌症,1989, 8(3):210.
|
7. Nou. E. The Natural Five-year Course in Bronchial Carcinoma Epidemiologic Resule cancer, 1984. 53:2211.
|
8. Repp. E, et al. Chemotherapy Can prolong Survival in patients with Advanced Non-small-cell lung Cancer Repport of a Canadi ian Multicerter Randomized Trial J. Clin oncol. 1988, 6:633.
|
9. Eagan RT. et al. phase 1 stady of cyclophosphamide. Adriamycin, and cis-Dichlorodim mineplatinum(I) by infusion in patients with Adnocorcinoma and large cellCarcinoma of the lung. Cancer Treat Rep. 1979, 63:1589.
|
10 Knost JA, et al. cyclophosphamide. Doxorubicin, and Cisplantin in the Treatment of advanced Non-small-cell lung Cancer. Cancer Treat Rep, 1981, 65:941.
|
11 Evans WK. et al, cyclophosphamide, Doxorubicin an-dcisplantin in the treaement of Non-small-cell bronchegcnic Carcinoma. Cancer treat Rep, 1981, 65:947.
|